Ghent start-up BIO INX and gelatine producer Rousselot are collaborating on a new, standardised biomedical-grade bioink for printing three-dimensional human tissue. The road to the clinic is now shorter than ever.

Developments in 3D bioprinting are moving fast. Bioinks are already being used to print eyeballs, organ parts and bones. Organs-on-a-chip are also making clever use of the technology. Unfortunately, many of the wonderful applications remain in the research phase and do not make it to the clinic,’ says Jasper van Hoorick, CEO of BIO INX. The problem lies in the lack of standardised biomaterials with a quality label.

But BIO INX has good news: thanks to a collaboration with Rousselot, the market leader in gelatine and collagen-based solutions, they are now developing a new bioink.